Mark Sheptoff Financial Planning’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Sell
12,734
-6,005
-32% -$160K 0.18% 70
2025
Q4
$467K Sell
18,739
-900
-5% -$22.7K 0.22% 65
2025
Q3
$500K Buy
19,639
+600
+3% +$14.8K 0.24% 57
2025
Q2
$461K Sell
19,039
-4,100
-18% -$95.6K 0.25% 59
2025
Q1
$586K Buy
23,139
+4,100
+22% +$107K 0.32% 51
2024
Q4
$505K Buy
19,039
+300
+2% +$8.14K 0.27% 56
2024
Q3
$542K Sell
18,739
-300
-2% -$8.75K 0.29% 54
2024
Q2
$533K Hold
19,039
0.3% 55
2024
Q1
$528K Sell
19,039
-1,749
-8% -$48.5K 0.29% 53
2023
Q4
$598K Sell
20,788
-3,990
-16% -$121K 0.36% 47
2023
Q3
$822K Sell
24,778
-9,247
-27% -$327K 0.53% 33
2023
Q2
$1.25M Hold
34,025
0.71% 29
2023
Q1
$1.39M Buy
34,025
+120
+0.4% +$5.18K 0.81% 24
2022
Q4
$1.74M Buy
33,905
+2,986
+10% +$143K 1.02% 21
2022
Q3
$1.35M Buy
30,919
+101
+0.3% +$4.91K 0.82% 24
2022
Q2
$1.62M Buy
30,818
+918
+3% +$46.8K 0.93% 22
2022
Q1
$1.55M Sell
29,900
-28,782
-49% -$1.49M 0.78% 28
2021
Q4
$3.46M Buy
58,682
+24,602
+72% +$1.22M 1.65% 12
2021
Q3
$1.47M Buy
34,080
+4,395
+15% +$195K 0.81% 25
2021
Q2
$1.16M Sell
29,685
-189
-0.6% -$7.35K 0.62% 30
2021
Q1
$1.08M Sell
29,874
-42,362
-59% -$1.5M 0.62% 30
2020
Q4
$2.66M Buy
72,236
+2,517
+4% +$92.3K 1.51% 16
2020
Q3
$2.43M Buy
69,719
+31,455
+82% +$1.1M 1.49% 17
2020
Q2
$1.19M Sell
38,264
-1,199
-3% -$40.7K 0.77% 33
2020
Q1
$1.22M Sell
39,463
-1,595
-4% -$54.3K 0.92% 27
2019
Q4
$1.53M Sell
41,058
-951
-2% -$33.9K 0.96% 25
2019
Q3
$1.43M Buy
42,009
+969
+2% +$35.2K 0.97% 28
2019
Q2
$1.69M Buy
41,040
+197
+0.5% +$7.82K 1.15% 21
2019
Q1
$1.65M Sell
40,843
-226
-0.6% -$9.05K 1.19% 20
2018
Q4
$1.7M Buy
41,069
+80
+0.2% +$3.32K 1.41% 19
2018
Q3
$1.71M Sell
40,989
-231
-0.6% -$8.89K 1.18% 21
2018
Q2
$1.42M Buy
41,220
+75
+0.2% +$2.56K 1.05% 22
2018
Q1
$1.39M Sell
41,145
-1,407
-3% -$48.4K 0.96% 26
2017
Q4
$1.46M Sell
42,552
-2,386
-5% -$81.4K 0.95% 27
2017
Q3
$1.52M Sell
44,938
-2,174
-5% -$69.9K 1.02% 26
2017
Q2
$1.5M Sell
47,112
-6,276
-12% -$198K 1.03% 25
2017
Q1
$1.73M Sell
53,388
-933
-2% -$29.4K 1.24% 21
2016
Q4
$1.67M Buy
54,321
+1,253
+2% +$38.3K 1.24% 18
2016
Q3
$1.71M Buy
53,068
+4,250
+9% +$142K 1.27% 25
2016
Q2
$1.63M Sell
48,818
-854
-2% -$27.3K 1.22% 24
2016
Q1
$1.4M Buy
49,672
+23,388
+89% +$668K 1.14% 27
2015
Q4
$805K Sell
26,284
-551
-2% -$17.3K 0.65% 40
2015
Q3
$800K Sell
26,835
-2,945
-10% -$94.4K 0.7% 38
2015
Q2
$947K Buy
29,780
+10,533
+55% +$343K 0.77% 38
2015
Q1
$635K Sell
19,247
-1,370
-7% -$43.6K 0.53% 52
2014
Q4
$609K Buy
20,617
+86
+0.4% +$2.47K 0.54% 54
2014
Q3
$576K Sell
20,531
-1,490
-7% -$41.8K 0.51% 57
2014
Q2
$620K Buy
22,021
+377
+2% +$10.7K 0.53% 56
2014
Q1
$660K Buy
+21,644
New +$645K 0.58% 51

Other funds holding PFE

Mark Sheptoff Financial Planning's PFE Position: Q1 2026 in Review

Mark Sheptoff Financial Planning reduced its Pfizer (PFE) stake by 32% in Q1 2026, selling an estimated $160K and leaving 12,734 shares worth $337K. The position accounts for 0.18% of the portfolio, ranked #70.

Mark Sheptoff Financial Planning first reported a position in PFE in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.46M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Mark Sheptoff Financial Planning held 12,734 shares of Pfizer worth $337K as of Q1 2026.
  • Mark Sheptoff Financial Planning sold 6,005 Pfizer shares in Q1 2026, an estimated $160K.
  • Pfizer made up 0.18% of Mark Sheptoff Financial Planning's portfolio in Q1 2026, its #70 holding.
  • Mark Sheptoff Financial Planning first reported a position in Pfizer in Q1 2014 and has held it in 49 quarters since.
  • Mark Sheptoff Financial Planning's Pfizer position peaked at $3.46M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2026, filed 11 May 2026.